{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T08:14:31Z","timestamp":1698653671379},"reference-count":21,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2002,4,24]],"date-time":"2002-04-24T00:00:00Z","timestamp":1019606400000},"content-version":"vor","delay-in-days":662,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2000,7]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Exposure to GB virus type C\/HGV (GBV\u2010C\/HGV) could be determined by detection either of RNA by RT\u2010PCR or of antibodies of the envelope protein E2.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> The aim of the study was to determine the proportion of the GBV\u2010C\/HGV markers of infection in a blood donor population infected with HCV and to identify GBV\u2010C\/HGV routes of transmission that are associated with HCV genotypes and risk factors.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> Among 306 HCV RNA\u2010positive blood donors, the proportion of GBV\u2010C\/HGV RNA\u2010positive donors and anti\u2010E2\u2010positive donors was 19.3 percent (95% CI = 15.0\u201024.2%) and 42.1 percent (95% CI = 36.6\u201047.9%), respectively. Exposure to GBV\u2010C\/HGV (RNA or anti\u2010E2) was significantly associated with the risk factor of IV drug use. There was a trend toward association with HCV subtypes 1a and 3a, probably because these HCV subtypes are the most frequent in IV drug users. No correlation was observed between ALT elevation and the presence of GBV\u2010C\/HGV RNA.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> In persons with HCV infection, IV drug use seems to be a major route of GBV\u2010C\/HGV transmission. Precautions taken to avoid HCV infection will probably also decrease GBV\u2010C\/HGV transmission.<\/jats:p>","DOI":"10.1046\/j.1537-2995.2000.40070875.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T22:43:19Z","timestamp":1047508999000},"page":"875-878","source":"Crossref","is-referenced-by-count":2,"title":["GB Virus type C\/HGV markers in HCV RNA\u2010positive French blood donors: correlation with HCV genotypes and risk factors"],"prefix":"10.1111","volume":"40","author":[{"given":"F.","family":"Bouchardeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Laperche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pillonel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.H.","family":"Elghouzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Maisonneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tirtaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Boiret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Razer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Girault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Courouc\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5248.505"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.8.3401"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/blood.V90.9.3776","article-title":"Natural history of GBV\u2010C\/hepatitis G virus infection through the follow\u2010up of GBV\u2010C\/hepatitis G virus\u2010infected blood donors and recipients studied by RNA polymerase chain reaction and anti\u2010E2 serology.","volume":"90","author":"Lefr\u00e8re JJ","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1182\/blood.V90.3.1326","article-title":"Hepatitis C and G virus infection and liver dysfunction after allogenic bone marrow transplantation: results from a prospective study.","volume":"90","author":"Rodriguez\u2010Inigo E","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.37697335162.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(98)80032-1"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.37697335161.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.2.458"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)06461-6"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0602"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.1999.7630166.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250630"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.6.1607"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/ndt\/10.12.2250","article-title":"Genotype distribution and transmission of hepatitis C virus (HCV) in French haemodialysed patients.","volume":"10","author":"Bouchardeau F","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606273342602"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-11-199706010-00004"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/314722"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39199116900.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80244-9"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.1998.7510077.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.11.2692"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1537-2995.2000.40070875.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1537-2995.2000.40070875.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T12:15:38Z","timestamp":1698581738000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1537-2995.2000.40070875.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["10.1046\/j.1537-2995.2000.40070875.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1537-2995.2000.40070875.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}